About: Michael Kaback

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Michael Kaback Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/c/4bTTUzEAC9

Michael M. Kaback, M.D. is a geneticist, physician, and Professor of Pediatrics and Reproductive Medicine, and chief of the Division of Medical Genetics, at the University of California–San Diego. He is best known for his role in the discovery and development of an enzyme assay method of screening for Tay–Sachs disease, a rare and fatal genetic disorder. This test allowed for cost-effective screening of large populations, the first such test in medical genetics. Because no large scale genetic screening had ever been done before, Kaback became involved in public health aspects of screening, including the education of target populations and genetic counseling. Although no cure for Tay–Sachs disease has been found, antenatal genetic screening has virtually eliminated the disease in the Ashken

Attributes	Values
rdf:type	Thing yago:WikicatAmericanGeneticists scientist yago:WikicatLivingPeople yago:Biologist109855630 yago:CausalAgent100007347 yago:Geneticist110126424 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scientist110560637 yago:Whole100003553
rdfs:label	Michael Kaback (en)
rdfs:comment	Michael M. Kaback, M.D. is a geneticist, physician, and Professor of Pediatrics and Reproductive Medicine, and chief of the Division of Medical Genetics, at the University of California–San Diego. He is best known for his role in the discovery and development of an enzyme assay method of screening for Tay–Sachs disease, a rare and fatal genetic disorder. This test allowed for cost-effective screening of large populations, the first such test in medical genetics. Because no large scale genetic screening had ever been done before, Kaback became involved in public health aspects of screening, including the education of target populations and genetic counseling. Although no cure for Tay–Sachs disease has been found, antenatal genetic screening has virtually eliminated the disease in the Ashken (en)
dcterms:subject	Living people Year of birth missing (living people) American geneticists Members of the National Academy of Medicine University of California, San Diego faculty
Wikipage page ID	10559541 (xsd:integer)
Wikipage revision ID	1097206154 (xsd:integer)
Link from a Wikipage to another Wikipage	Living people Year of birth missing (living people) Enzyme American geneticists Members of the National Academy of Medicine Robert J. Desnick Tay–Sachs disease Ashkenazi Jews University of California, San Diego faculty University of California–San Diego National Institutes of Health
sameAs	Michael Kaback Michael Kaback Michael Kaback Michael Kaback Michael Kaback
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:BLP_sources dbt:Citation_needed dbt:ISBN dbt:Reflist dbt:Short_description dbt:US-academic-scientist-stub
has abstract	Michael M. Kaback, M.D. is a geneticist, physician, and Professor of Pediatrics and Reproductive Medicine, and chief of the Division of Medical Genetics, at the University of California–San Diego. He is best known for his role in the discovery and development of an enzyme assay method of screening for Tay–Sachs disease, a rare and fatal genetic disorder. This test allowed for cost-effective screening of large populations, the first such test in medical genetics. Because no large scale genetic screening had ever been done before, Kaback became involved in public health aspects of screening, including the education of target populations and genetic counseling. Although no cure for Tay–Sachs disease has been found, antenatal genetic screening has virtually eliminated the disease in the Ashkenazi Jewish population in both the United States and Israel. In 1979, Kaback served on the first National Institutes of Health (NIH) panel to recommend antenatal diagnosis in cases where a couple might be at risk for conceiving a child with a hereditary disease or congenital defect. The panel brought together physicians, scientists, consumers, and others in order to develop a consensus statement for use by health care providers. In the NIH Consensus Development Program, panel members are selected for their expertise to serve as judges of evidence, and must have no prior conflicts of interest. Panel members addressed issues concerning the relative risks and benefits of genetic screening, including the costs and risks of the screening procedures themselves. It was the first NIH panel to provide recommendations for genetic screening, and its findings have since been revised many times. (en)
gold:hypernym	Geneticist
prov:wasDerivedFrom	wikipedia-en:Michael_Kaback?oldid=1097206154&ns=0
page length (characters) of wiki page	3641 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Michael_Kaback
is Link from a Wikipage to another Wikipage of	Prevention of Tay–Sachs disease Howard Ronald Kaback David Rimoin List of members of the National Academy of Medicine Robert J. Desnick Harbor–UCLA Medical Center Kaback, Michael William Allan Award
is Wikipage redirect of	Kaback, Michael
is foaf:primaryTopic of	wikipedia-en:Michael_Kaback

Faceted Search & Find service v1.17_git147 as of Sep 06 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3332 as of Dec 5 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 51 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software